JILL GALLEY: Open Payments
NPI 1417391087 · BUFFALO, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,757 in 83 payments from 20 companies in 2025. Trend: 2023 $1,041 · 2024 $1,788 · 2025 $1,757
Food & beverage: $1,757
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $267 |
| Novo Nordisk Inc | 14 | $198 |
| Viatris Specialty LLC | 5 | $168 |
| ABBVIE INC. | 8 | $161 |
| Lilly USA, LLC | 7 | $143 |
| Otsuka America Pharmaceutical, Inc. | 4 | $104 |
| Exact Sciences Corporation | 4 | $99 |
| PFIZER INC. | 4 | $84 |
| SHIELD THERAPEUTICS INC | 5 | $84 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $82 |
Products named: YUPELRI, REXULTI, FARXIGA, MOUNJARO, VRAYLAR, The Cologuard Plus Collection Kit, ACCRUFER, CAPLYTA.
Industry payments across NY — which companies pay providers there.
